These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37010843)

  • 41. Effects of the Rome IV Criteria to Functional Dyspepsia Symptoms in Saudi Arabia: Epidemiology and Clinical Practice.
    Zacharakis G; Al-Ghamdi S; AlZahrani J; Almasoud A; Arahmane O; AlShehri A; Alharbi MH; Alsalmi MM; Alotibi SB; Algaradi YA; Alsadiq FN; Nikolaidis P
    Korean J Gastroenterol; 2020 Dec; 76(6):304-313. PubMed ID: 33361706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and Associated Factors of Bloating: Results From the Rome Foundation Global Epidemiology Study.
    Ballou S; Singh P; Nee J; Rangan V; Iturrino J; Geeganage G; Löwe B; Bangdiwala SI; Palsson OS; Sperber AD; Lembo A; Lehmann M
    Gastroenterology; 2023 Sep; 165(3):647-655.e4. PubMed ID: 37315866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of Rome IV Pediatric Diagnostic Questionnaire-Assessed Disorder of Gut-Brain Interaction, Psychopathological Comorbidities and Consumption of Ultra-Processed Food in Pediatric Anorexia Nervosa.
    Rurgo S; Marchili MR; Spina G; Roversi M; Cirillo F; Raucci U; Sarnelli G; Raponi M; Villani A
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut-brain interaction.
    Fairlie T; Shah A; Wong RK; Fang X; Ghoshal UC; Kashyap PC; Mulak A; Lee YY; Sperber AD; Koloski N; Moy N; Talley NJ; Jones MP; Holtmann G
    Neurogastroenterol Motil; 2024 Sep; 36(9):e14866. PubMed ID: 39005136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
    Black CJ; Houghton LA; Ford AC
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14391. PubMed ID: 35531932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life measures in children with Down syndrome with disorders of gut-brain interaction.
    Ciciora SL; Manickam K; Saps M
    Am J Med Genet C Semin Med Genet; 2023 Dec; 193(4):e32071. PubMed ID: 37882146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.
    Fairbrass KM; Selinger CP; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14256. PubMed ID: 34472157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Symptom profiles compatible with disorders of gut-brain interaction (DGBI) in organic gastrointestinal diseases: A global population-based study.
    van Gils T; Hreinsson JP; Törnblom H; Tack J; Bangdiwala SI; Palsson OS; Sperber AD; Simrén M
    United European Gastroenterol J; 2024 Sep; 12(7):834-847. PubMed ID: 38975964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut-Brain Interaction Disorders and Anorexia Nervosa: Psychopathological Asset, Disgust, and Gastrointestinal Symptoms.
    Carpinelli L; Savarese G; Pascale B; Milano WD; Iovino P
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.
    Aziz I; Palsson OS; Törnblom H; Sperber AD; Whitehead WE; Simrén M
    Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):252-262. PubMed ID: 29396034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Global Prevalence and Impact of Rumination Syndrome.
    Josefsson A; Hreinsson JP; Simrén M; Tack J; Bangdiwala SI; Sperber AD; Palsson OS; Törnblom H
    Gastroenterology; 2022 Mar; 162(3):731-742.e9. PubMed ID: 34774539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Breen-Lyles M; Decuir M; Byale A; Smith K; Grover M
    Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating disorders of gut-brain interaction in eating disorders.
    Wiklund CA; Rania M; Kuja-Halkola R; Thornton LM; Bulik CM
    Int J Eat Disord; 2021 Jun; 54(6):925-935. PubMed ID: 33955041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multicenter registry study on percutaneous electrical nerve field stimulation for pediatric disorders of gut-brain interaction.
    Chogle A; El-Chammas K; Santucci N; Grimm M; Dorfman L; Graham K; Kelly DR; Dranove JE; Rosen R; Nurko S; Croffie J; Balakrishnan K; Chiou EH; Zhang L; Simpson P; Karrento K
    J Pediatr Gastroenterol Nutr; 2024 Apr; 78(4):817-826. PubMed ID: 38451058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology and Burden of Irritable Bowel Syndrome: An International Perspective.
    Sperber AD
    Gastroenterol Clin North Am; 2021 Sep; 50(3):489-503. PubMed ID: 34304784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The epidemiology and quality of life of functional gastrointestinal disorders according to Rome III vs Rome IV criteria: A cross-sectional study in primary care.
    Chuah KH; Beh KH; Mahamad Rappek NA; Mahadeva S
    J Dig Dis; 2021 Mar; 22(3):159-166. PubMed ID: 33595169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disorders of Gut-Brain Interaction in a National Cohort of Children With Down Syndrome.
    Ciciora SL; Manickam K; Saps M
    J Neurogastroenterol Motil; 2023 Jan; 29(1):94-101. PubMed ID: 36606440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.
    Aziz I; Palsson OS; Törnblom H; Sperber AD; Whitehead WE; Simrén M
    Am J Gastroenterol; 2018 Jan; 113(1):86-96. PubMed ID: 29134969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?
    Sperber AD; Shvartzman P; Friger M; Fich A
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):441-7. PubMed ID: 17489053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.